Albuminex Solution
Product Images NDC 64208-2510

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Albuminex (NDC 64208-2510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bpl, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (500 mL Vial Label)

Principal Display Panel (500 mL Vial Label)
Albuminex 5% is a solution for infusion to be used intravenously. It is important to not use if turbid and to refer to the package insert for directions for use and dosage information. The product is manufactured by Products Laboratory Ltd. in the UK and distributed by BPL USA in Durham, USA. The NDC number is 64208-2510-6.*
FDA Label Image

Principal Display Panel (500 mL Vial Carton)

Principal Display Panel (500 mL Vial Carton)
This is a description of Albuminex® 5% solution for infusion, which contains human albumin for intravenous use. The solution is stabilized with caprylate and acetyltryptophanate and has a sodium content of 130-160 mEQ/L. The product should be used with caution in the presence of dehydration and it is recommended to discuss the risks and benefits before use. The package insert provides directions for use and dosage information. The product does not contain any preservatives and should not be used if turbid. The vial should not be used 4 hours after being opened and should be stored below 30°C.*
FDA Label Image

Principal Display Panel (250 mL Vial Label)

Principal Display Panel (250 mL Vial Label)
This is a label of ALBUMINEX 5%, which is a solution for infusion meant for intravenous use only. It contains albumin (human). The label includes directions for use, information on dosage, and precautionary notes. The manufacturer is Bl Products Laboratory Ltd located in the UK. The label also bears distributor information for BPL USA Inc.*
FDA Label Image

Principal Display Panel (250 mL Vial Carton)

Principal Display Panel (250 mL Vial Carton)
Albuminex 5% is a solution for infusion intended for intravenous use only. It contains 125g of Albumin (Human) in 250 mL of aqueous buffer which is osmotically equivalent to 250 mL of plasma. The product is stabilized with 4 mmol/L caprylate and 4 mmol/L acetyltryptophanate. The sodium content of the product is 130-160 MEQ/L and the aluminum content is less than 200 micrograms/L. It is distributed in the United Kingdom and the USA. The patient and physician should discuss the risks and benefits before using this product. It is available in 1 vial and contains no preservative.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.